跳至主要内容
临床试验/NCT06596785
NCT06596785进行中(未招募)不适用

Investigation and Early Risk Prediction of Acute Kidney Injury Caused by Iodinated Contrast Agents: Development of CI-AKIDPi Model Based on Interpretable Deep Learning

Xiao Li,MD1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2024年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
2,000
试验地点
1
主要终点
AKI

研究概览

简要总结

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent.

详细描述

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent. Despite the frequent use of iodinated contrast agents in medical investigations, predictive models for CI-AKI are scarce. This study aimed to construct and validate interpretable deep learning models for the early risk prediction of acute kidney injury (AKI) associated with iodinated contrast agents.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who received iodinated contrast agents during hospitalization
  • age ≥ 18 years
  • hospitalization length ≥ 48 hours
  • at least two serum creatinine tests during hospitalization

排除标准

  • patients with stage 4 or 5 chronic kidney disease prior to admission
  • patients undergoing hemodialysis, hemofiltration or peritoneal before admission
  • a history of nephrectomy or kidney transplantation during hospitalization
  • incomplete clinical information
  • Serum creatinine always ≤ 40 μmol/L during hospitalization

结局指标

主要结局

AKI

时间窗: Completed through study, up to half a year

During the patient's hospitalization, acute kidney injury occurred after the use of Iodinated contrast media

次要结局

未报告次要终点

研究者

发起方
Xiao Li,MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Xiao Li,MD

Associate professor of pharmacy

Qianfoshan Hospital

研究点 (1)

Loading locations...

相似试验